关注
Stuti Biswal
Stuti Biswal
PhD Scholar, Cancer Drug Resistance Laboratory, NIT Rourkela, Odisha
在 nitrkl.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer
S Biswal, M Panda, RK Sahoo, SK Tripathi, BK Biswal
Archives of Oral Biology 151, 105697, 2023
72023
Transforming native exosomes to engineered drug vehicles: A smart solution to modern cancer theranostics
RK Sahoo, SK Tripathi, S Biswal, M Panda, SS Mathapati, BK Biswal
Biotechnology Journal 19 (2), 2300370, 2024
22024
Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β‐catenin axis
M Panda, S Biswal, BK Biswal
Molecular Biology Reports 51 (1), 523, 2024
12024
Enigmatic exosomal connection in lung cancer drug resistance
SK Patra, RK Sahoo, S Biswal, SS Panda, BK Biswal
Molecular Therapy-Nucleic Acids, 2024
12024
Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance
SS Panda, RK Sahoo, SK Patra, S Biswal, BK Biswal
Drug Discovery Today, 104061, 2024
2024
Shikonin suppresses cell proliferation by inducing apoptosis in oral cancer
S Biswal, M Panda, BK Biswal
2022
系统目前无法执行此操作,请稍后再试。
文章 1–6